References
Baek YS, Jeon J, Kim A, Song HJ, Kim C. Human papillomavirus is more frequently detected in the pelvic than non-pelvic area in patients with squamous cell carcinoma in situ (Bowen’s disease). Eur J Dermatol 2020; 30: 111–8.
Sarig O, Sprecher E. The molecular revolution in cutaneous biology: era of next generation sequencing. J Invest Dermatol 2017; 137: e79–82.
Ambulos NP Jr., Schumaker LM, Mathias TJ, et al. Next-generation sequencing-based HPV genotyping assay validated in formalin fixed, paraffin-embedded oropharyngeal and cervical cancer specimens. J Biomol Tech 2016; 27: 46–52.
Liang L, Zhang Y-M, Chen H. Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis. Eur J Dermatol 2020; 30: 151–8.
Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985; 28: 796–803.
Srivastava P, Dwivedi S, Misra R. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis. Rheumatol Int 2016; 36: 35–943.
Hamaguchi Y, Kuwana M, Hoshino K, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 2011; 147: 391–8.
Petri MH, Satoh M, Martin-Marquez BT, et al. Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara. Arthritis Res Ther 2013; 15: R48.
Farutin V, Prod’homme T, McConnell K, et al. Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor. Arthritis Res Ther 2019; 21: 216.
Bauzá Quetglas JL, Tienza Fernández A, Bertolo R, et al. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with testicular cancer. Prog Urol 2020. doi: https://doi.org/10.1016/j.purol.2020.02.002.
Sheng IY, Diaz-Montero CM, Rayman P, et al. Blood myeloid-derived suppressor cells correlate with neutrophil-to-lymphocyte ratio and overall survival in metastatic urothelial carcinoma. Target Oncol 2020. doi: https://doi.org/10.1007/s11523-020-00707-z.
Zhang S-H, Peng Y, Xie Q-B, Yin G, Yan B. Risk factors of respiratory failure in the dermatomyositis patients with interstitial lung disease. Sichuan Da Xue Xue Bao Yi Xue Ban 2018; 49: 188–94.
Nicoletis I, Pasco J, Maillot F, et al. High pre-treatment neutrophil-to-lymphocyte ratio in patients with dermatomyositis/polymyositis predicts an increased risk of cancer. Eur J Dermatol 2020; 30: 133–9.
Ha Y-J, Hur J, Go DJ, et al. Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: a retrospective observational study. PLoS One 2018; 13: e0190411.
Gao M-Z, Huang Y-L, Wu X-D, et al. Red blood cell distribution width and neutrophil to lymphocyte ratio are correlated with disease activity of dermatomyositis and polymyositis. J Clin Lab Anal 2018; 32: 1.
Miura T, Kikuchi N, Yamamoto T. Cutaneous sarcoidosis in 95 Japanese patients: a single institutional study. Eur J Dermatol 2020; 30: 205–6.
Chong W-S, Tan H-H, Tan S-H. Cutaneous sarcoidosis in Asians: a report of 25 patients from Singapore. Clin Exp Dermatol 2005; 30: 120–4.
Rybicki BA, Maliarik MJ, Major M, Popovich J, Iannuzzi MC. Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 1998; 13: 166–73.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure
Conflicts of interest: none.
About this article
Cite this article
Vilas Boas, P., Frings, V., Gran, F. et al. What’s new this month?. Eur J Dermatol 30, 210–211 (2020). https://doi.org/10.1684/ejd.2020.3791
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2020.3791